Epiminder Limited (ASX:EPI)

Market Cap	170.92M
Revenue (ttm)	445.18K -91.5%
Net Income	-31.78M
EPS	-0.57
Shares Out	216.35M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	153,035
Average Volume	107,287
Open	0.7700
Previous Close	0.7700
Day's Range	0.7700 - 0.7900
52-Week Range	0.7650 - 1.4900
Beta	n/a
RSI	27.28
Earnings Date	Feb 24, 2026

About Epiminder

Epiminder Limited develops and manufactures a monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. It offers Minder system, an implantable sub scalp electroencephalography (EEG) monitoring system which is designed for continuous monitoring of brain activity. The company’s Minder system comprises Minder implant, a sub scalp electrode with multiple recording points which enables capture of EEG continuously for months or years; Minder wearable, which receives and stores EEG recordings wireles...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2017
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EPI

Financial Performance

In fiscal year 2025, Epiminder's revenue was 445,183, a decrease of -91.52% compared to the previous year's 5.25 million. Losses were -31.78 million, 91.5% more than in 2024.